Executive Management

Timothy J. Barberich
Chairman of the Board and Chief Executive Officer

Adrian Adams
President and Chief Operating Officer

David P. Southwell
Executive Vice President and Chief Financial Officer

William J. O’Shea
Vice Chairman

Mark H.N. Corrigan, M.D.
Executive Vice President, Research and Development

Robert F. Scumaci
Executive Vice President, Finance and Administration and Treasurer

Andrew I. Koven
Executive Vice President, General Counsel and Corporate Secretary


Directors

Adrian Adams
President and Chief Operating Officer, Sepracor Inc.

James G. Andress
Former Chairman, Beecham Pharmaceuticals, Former President and COO, Sterling Drug Inc.

Timothy J. Barberich
Chairman of the Board and Chief Executive Officer, Sepracor Inc.

Digby W. Barrios
Former President and CEO, Boehringer Ingelheim Corporation

Robert J. Cresci
Managing Director, Pecks Management Partners Ltd.

James F. Mrazek
Former Vice President and General Manager, Healthcare Division of Johnson & Johnson Products Inc.

Timothy J. Rink, MA, M.D., Sc.D.
Former Chairman and Chief Executive Officer, Aurora Biosciences, Inc.,
Former President and Chief Technical Officer, Amylin Pharmaceuticals, Inc.

Alan A. Steigrod
Former Executive Vice President, Glaxo Holdings plc

         
 
         

BROVANA is a trademark and XOPENEX, LUNESTA and XOPENEX HFA are registered trademarks of Sepracor Inc. Other trademarks or service marks appearing in this report are the property of their respective owners.

Design: MediaConcepts Corporation, Assonet, MA www.mediaconceptscorp.com